BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25570683)

  • 1. Dynamic tension EMG to characterize the effects of DBS treatment of advanced Parkinson's disease.
    Ruonala V; Pekkonen E; Rissanen S; Airaksinen O; Miroshnichenko G; Kankaanpää M; Karjalainen P
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():3248-51. PubMed ID: 25570683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal features of surface electromyography in advanced Parkinson's disease during different settings of deep brain stimulation.
    Rissanen SM; Ruonala V; Pekkonen E; Kankaanpää M; Airaksinen O; Karjalainen PA
    Clin Neurophysiol; 2015 Dec; 126(12):2290-8. PubMed ID: 25727899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in elbow flexion EMG morphology during adjustment of deep brain stimulator in advanced Parkinson's disease.
    Ruonala V; Pekkonen E; Airaksinen O; Kankaanpää M; Karjalainen PA; Rissanen SM
    PLoS One; 2022; 17(4):e0266936. PubMed ID: 35421176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson's disease.
    Qureshi AA; Cheng JJ; Sunshine AN; Wu A; Pontone GM; Cascella N; Lenz FA; Grill SE; Anderson WS
    Neurosurg Focus; 2015 Jun; 38(6):E5. PubMed ID: 26030705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel assistive method for rigidity evaluation during deep brain stimulation surgery using acceleration sensors.
    Shah A; Coste J; Lemaire JJ; Schkommodau E; Taub E; Guzman R; Derost P; Hemm S
    J Neurosurg; 2017 Sep; 127(3):602-612. PubMed ID: 27982769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study.
    Vitek JL; Jain R; Chen L; Tröster AI; Schrock LE; House PA; Giroux ML; Hebb AO; Farris SM; Whiting DM; Leichliter TA; Ostrem JL; San Luciano M; Galifianakis N; Verhagen Metman L; Sani S; Karl JA; Siddiqui MS; Tatter SB; Ul Haq I; Machado AG; Gostkowski M; Tagliati M; Mamelak AN; Okun MS; Foote KD; Moguel-Cobos G; Ponce FA; Pahwa R; Nazzaro JM; Buetefisch CM; Gross RE; Luca CC; Jagid JR; Revuelta GJ; Takacs I; Pourfar MH; Mogilner AY; Duker AP; Mandybur GT; Rosenow JM; Cooper SE; Park MC; Khandhar SM; Sedrak M; Phibbs FT; Pilitsis JG; Uitti RJ; Starr PA
    Lancet Neurol; 2020 Jun; 19(6):491-501. PubMed ID: 32470421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.
    Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM
    Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease.
    Vaillancourt DE; Prodoehl J; Verhagen Metman L; Bakay RA; Corcos DM
    Brain; 2004 Mar; 127(Pt 3):491-504. PubMed ID: 14662520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem.
    Holiga Š; Mueller K; Möller HE; Urgošík D; Růžička E; Schroeter ML; Jech R
    Neuroimage Clin; 2015; 9():264-74. PubMed ID: 26509113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single electrode and multiple electrode guided electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Temel Y; Wilbrink P; Duits A; Boon P; Tromp S; Ackermans L; van Kranen-Mastenbroek V; Weber W; Visser-Vandewalle V
    Neurosurgery; 2007 Nov; 61(5 Suppl 2):346-55; discussion 355-7. PubMed ID: 18091250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.
    Stefani A; Lozano AM; Peppe A; Stanzione P; Galati S; Tropepi D; Pierantozzi M; Brusa L; Scarnati E; Mazzone P
    Brain; 2007 Jun; 130(Pt 6):1596-607. PubMed ID: 17251240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of EMG and acceleration signals for quantifying the effects of deep brain stimulation in Parkinson's disease.
    Rissanen SM; Kankaanpää M; Tarvainen MP; Novak V; Novak P; Hu K; Manor B; Airaksinen O; Karjalainen PA
    IEEE Trans Biomed Eng; 2011 Sep; 58(9):2545-53. PubMed ID: 21672674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial.
    Okun MS; Gallo BV; Mandybur G; Jagid J; Foote KD; Revilla FJ; Alterman R; Jankovic J; Simpson R; Junn F; Verhagen L; Arle JE; Ford B; Goodman RR; Stewart RM; Horn S; Baltuch GH; Kopell BH; Marshall F; Peichel D; Pahwa R; Lyons KE; Tröster AI; Vitek JL; Tagliati M;
    Lancet Neurol; 2012 Feb; 11(2):140-9. PubMed ID: 22239915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic nucleus stimulation, dopaminergic treatment and impulsivity in Parkinson's disease.
    Fluchère F; Burle B; Vidal F; van den Wildenberg W; Witjas T; Eusebio A; Azulay JP; Hasbroucq T
    Neuropsychologia; 2018 Aug; 117():167-177. PubMed ID: 29458074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Objective measurement of muscle rigidity in Parkinsonian patients treated with subthalamic stimulation.
    Levin J; Krafczyk S; Valkovic P; Eggert T; Claassen J; Bötzel K
    Mov Disord; 2009 Jan; 24(1):57-63. PubMed ID: 18855925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.
    Timmermann L; Jain R; Chen L; Maarouf M; Barbe MT; Allert N; Brücke T; Kaiser I; Beirer S; Sejio F; Suarez E; Lozano B; Haegelen C; Vérin M; Porta M; Servello D; Gill S; Whone A; Van Dyck N; Alesch F
    Lancet Neurol; 2015 Jul; 14(7):693-701. PubMed ID: 26027940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.